Elizabeth Plimack MD @erplimackmd.bsky.social · 15/02/2025Comparison of Adjuvant regimens for cancer across tumor types #GU25. Nivolumab per Checkmate 274 for #bladdercancer rises to the top. docs.google.com/presentation... 083
